Mydekla 60Mg 28 Tablets contains Daclatasvir, which belongs to the class of hepatitis C virus (HCV) NS5A inhibitors. It works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and, therefore, reduces the amount of hepatitis C virus in the body.

FAQs

How does Mydekla 60Mg 28 Tablets work?

Mydekla 60Mg 28 Tablets contains Daclatasvir, which works by blocking the activity of the hepatitis C virus in the liver cells. This causes viral DNA termination and reduces the amount of hepatitis C virus in the body.

What are the contraindications of Mydekla 60Mg 28 Tablets?

Avoid receiving Mydekla 60Mg 28 Tablets if you are allergic to it or other medicines of the same class. Also, this medicine should not be used along with CYP3A inducer drugs such as rifampicin, carbamazepine, phenytoin, etc., as it can cause serious adverse effects. Concomitant use of Mydekla 60Mg 28 Tablets along with amiodarone should be avoided due to the risk of severe bradycardia (slow heart rate).